Evidence map›Paper›PMID 31724052›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2020

Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse.

David W Frank, Paul M Cinciripini, Menton M Deweese, Maher Karam-Hage, George Kypriotakis, Caryn Lerman, Jason D Robinson, Rachel F Tyndale, Damon J Vidrine, Francesco Versace

Open access · greenAbstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

David W FrankDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Paul M CinciripiniDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Menton M DeweeseDepartment of Teaching and Learning, Peabody College at Vanderbilt University, Nashville, TN.
Maher Karam-HageDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
George KypriotakisDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Caryn LermanDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA.
Jason D RobinsonDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
Rachel F TyndaleCampbell Family Mental Health Research Institute, Center for Addiction and Mental Health, Departments of Psychiatry, Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Damon J VidrineStephenson Cancer Center, Oklahoma Tobacco Research Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Francesco VersaceDepartment of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX.
The University of Texas MD Anderson Cancer Center · USCentre for Addiction and Mental Health · CAUniversity of Oklahoma Health Sciences Center · USUniversity of Pennsylvania · USVanderbilt University · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
University of Toronto Coordinating Genetics Core & Clinical Trial SiteU01DA020830 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI CONTI, DAVID V · 2005 to 2014
$22.4M
Incentive salience and the neuropsychological underpinnings of cue-induced smoking relapseR01DA032581 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI VERSACE, FRANCESCO · 2012 to 2024
$2.5M
Neurobehavioral Assessment of Reward Sensitivity in Young SmokersR21DA038001 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI VERSACE, FRANCESCO · 2015 to 2016
$423k
CIHR FDN-154294NCI NIH HHS P30 CA016672NIDA NIH HHS R01 DA032581NIDA NIH HHS R21 DA038001NIDA NIH HHS U01 DA020830
6 · The paper itself

Abstract

introductionBy improving our understanding of the neurobiological mechanisms underlying addiction, neuroimaging research is helping to identify new targets for personalized treatment interventions. When trying to quit, smokers with larger electrophysiological responses to cigarette-related, compared with pleasant, stimuli ("C > P") are more likely to relapse than smokers with the opposite brain reactivity profile ("P > C"). AIM AND

methodThe goal was to (1) build a classification algorithm to identify smokers characterized by P > C or C > P neuroaffective profiles and (2) validate the algorithm's classification outcomes in an independent data set where we assessed both smokers' electrophysiological responses at baseline and smoking abstinence during a quit attempt. We built the classification algorithm applying discriminant function analysis on the event-related potentials evoked by emotional images in 180 smokers.

resultsThe predictive validity of the classifier showed promise in an independent data set that included new data from 177 smokers interested in quitting; the algorithm classified 111 smokers as P > C and 66 as C > P. The overall abstinence rate was low; 15 individuals (8.5% of the sample) achieved CO-verified 12-month abstinence. Although individuals classified as P > C were nearly 2.5 times more likely to be abstinent than smokers classified as C > P (12 vs. 3, or 11% vs. 4.5%), this result was nonsignificant, preliminary, and in need of confirmation in larger trials.

conclusionThese results suggest that psychophysiological techniques have the potential to advance our knowledge of the neurobiological underpinnings of nicotine addiction and improve clinical applications. However, larger sample sizes are necessary to reliably assess the predictive ability of our algorithm. IMPLICATIONS: We assessed the clinical relevance of a neuroimaging-based classification algorithm on an independent sample of smokers enrolled in a smoking cessation trial and found those with the tendency to attribute more relevance to rewards than cues were nearly 2.5 times more likely to be abstinent than smokers with the opposite brain reactivity profile (11% vs. 4.5%). Although this result was not statistically significant, it suggests our neuroimaging-based classification algorithm can potentially contribute to the development of new precision medicine interventions aimed at treating substance use disorders. Regardless, these findings are still preliminary and in need of confirmation in larger trials.

Indexed as

AlgorithmsPrecision MedicineFemaleHumansMaleMiddle AgedNeuroimagingRecurrenceSmokersSmoking CessationTobacco Use DisorderUnited States

Identifiers

PMID31724052
PMCPMC7364823
OpenAlexW2983958955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.